Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine Plus Bupivacaine in Septoplasty
NCT03926663Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Jul 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine (2 arms), sponsored by Cairo University. Primary endpoint: Percentage of patients requiring rescue drugs (nitroglycerin, propranolol) at 3 hours. Status: unknown.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT03926663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03926663.